PATENT CLAIM ANALYSIS

Application Number: 16069326
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["546", "156000"]

Abstract:
Compounds of the formula I in which X 1 , X 2 , X 3 , X 4 , R 1 , R 2 , R 3 , Q and Y have the meanings indicated in Claim  1,  are inhibitors of c-Kit kinase, and can be employed for the treatment of cancer.

Claim (Index 3):
Compounds according to  claim 1 , in which\n R 3  denotes phenyl, pyridyl, pyrimidinyl, indolyl, indazolyl, thiophenyl, dihydroisoindolyl or benzimidazolyl, each of which is unsubstituted or mono-, di- or trisubstituted by Hal, A, (CR 4 ) n OR 4 , (CR 4 ) n N(R 4 ) 2 , (CR 4 ) n S(O) m R 4 , (CR 4 ) n CON(R 4 ) 2 , (CR 4 ) n COHet, (CR 4 ) n SO 2 Het, (CR 4 ) n Het, O(CR 4 ) n COHet, (CR 4 ) n O(CR 4 ) n Het, (CR 4 ) n N(R 4 )(CR 4 ) n Het, (CR 4 ) n CON(R 4 )(CR 4 ) n Het, (CR 4 ) n CON(R 4 )(CR 4 ) n N(R 4 ) 2 , (CR 4 ) n N(R 4 )COA, (CR 4 ) n N(R 4 )COHet\u2032, (CR 4 ) n OCyc and/or (CR 4 ) n COOR 4 , and pharmaceutically acceptable salts, tautomers and stereoisomers thereof, including mixtures thereof in all ratios.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 95.0
- Lexical Diversity: 1.71875
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14909365', '15566933', '13546039', '14772865', '14908217']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7855877397072425
- 35 USC 102 Novelty (BERT): 0.532308460072545
- Combined Prediction Score: 0.7602598117437728
- Mean Citation Score: 331.6542
- Max Citation Score: 348.71225
- Similarity Product: 257.5684343440533

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test